Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX VISTA for masseter muscle prominence
jRCT2031230467Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in masseter hypertrophy (4 arms), sponsored by AbbVie Inc. Started Nov 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
masseter hypertrophy
Beyond the preview
Go deeper on jRCT2031230467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230467.